Amivantamab

ATC L01FX18 · 11 markets · 35 records

Amivantamab 11 markets · 35 records Forms

AU 7 records · 7 strengths

350 mginjectionRYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial also in US·CN unknown
350 mg/7 mLinjectionRybrevant also in GB·SG
3,520 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
2,400 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
1,600 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial also in ES unknown
2,240 mginjectionRYBREVANT SC amivantamab 1600mg/10mL solution for injection vial unknown

Records without a stated strength · 1 Rybrevant

US 5 records · 5 strengths

350 mginjectionRybrevant also in AU·CN
3,520 mg/22 mLinjectionRybrevant Faspro also in GB
2,400 mg/15 mLinjectionRybrevant Faspro also in GB
2,240 mg/14 mLinjectionRybrevant Faspro also in GB
1,600 mg/10 mLinjectionRybrevant Faspro also in GB

GB 5 records · 5 strengths

350 mg/7 mLinjectionRybrevant 350mg/7ml concentrate for solution for infusion vials also in AU·SG
3,520 mg/22 mLinjectionRybrevant 1600mg/10ml solution for injection vials also in US
2,400 mg/15 mLinjectionRybrevant 1600mg/10ml solution for injection vials also in US
2,240 mg/14 mLinjectionRybrevant 1600mg/10ml solution for injection vials also in US
1,600 mg/10 mLinjectionRybrevant 1600mg/10ml solution for injection vials also in US

CA 5 records · 2 strengths

160 mg/1 mLliquidRYBREVANT SC
50 mg/1 mLliquidRybrevant

ES 5 records · 5 strengths

3,520 mginjectionRybrevant also in AU
2,400 mginjectionRybrevant also in AU
1,600 mginjectionRybrevant also in AU
160 mg/1 mLinjectionRybrevant
50 mg/1 mLinjectionRybrevant

MX 2 records · 1 strengths

Records without a stated strength · 1 Rybrevant、Rybrevant Faspro

TW 2 records · 2 strengths

160 mginjectionRybrevant Solution for Injection 160 mg/mL+1肺倍恩皮下注射劑160毫克/毫升
50 mginjectionRybrevant Concentrate for Solution for Infusion 50mg/ml+1肺倍恩注射劑 50毫克/毫升

SG 1 records · 1 strengths

350 mg/7 mLinjectionRYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML also in AU·GB

CN 1 records · 1 strengths

350 mginjection锐珂埃万妥单抗 also in AU·US

HK 1 records · 1 strengths

Records without a stated strength · 1 RYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Rybrevant

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	MX	TW	HK	EU
350 mg injection	Rybrevant	not recorded	not recorded	RYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial	not recorded	锐珂埃万妥单抗	not recorded	not recorded	not recorded	not recorded	not recorded
350 mg/7 mL injection	not recorded	Rybrevant 350mg/7ml concentrate for solution for infusion vials	not recorded	Rybrevant	RYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
3,520 mg/22 mLRecorded as: 3.52 g/22 mL injection	Rybrevant Faspro	Rybrevant 1600mg/10ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
3,520 mg injection	not recorded	not recorded	not recorded	RYBREVANT SC amivantamab 1600mg/10mL solution for injection vial	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded
2,400 mg/15 mLRecorded as: 2.4 g/15 mL injection	Rybrevant Faspro	Rybrevant 1600mg/10ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
2,400 mg injection	not recorded	not recorded	not recorded	RYBREVANT SC amivantamab 1600mg/10mL solution for injection vial	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded
2,240 mg/14 mLRecorded as: 2.24 g/14 mL injection	Rybrevant Faspro	Rybrevant 1600mg/10ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
1,600 mg/10 mLRecorded as: 1.6 g/10 mL injection	Rybrevant Faspro	Rybrevant 1600mg/10ml solution for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
1,600 mg injection	not recorded	not recorded	not recorded	RYBREVANT SC amivantamab 1600mg/10mL solution for injection vial	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded
160 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rybrevant Solution for Injection 160 mg/mL 肺倍恩皮下注射劑160毫克/毫升	not recorded	not recorded
50 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rybrevant Concentrate for Solution for Infusion 50mg/ml 肺倍恩注射劑 50毫克/毫升	not recorded	not recorded
160 mg/1 mL liquid	not recorded	not recorded	RYBREVANT SC	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg/1 mL liquid	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
2,240 mg injection	not recorded	not recorded	not recorded	RYBREVANT SC amivantamab 1600mg/10mL solution for injection vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
160 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded
50 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Rybrevant	not recorded	not recorded	not recorded	not recorded	not recorded	RYBREVANT CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/7ML	Rybrevant
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rybrevant Rybrevant Faspro	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

5 more strength/form rows are recorded only in CA · MX · TW and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en CA · MX · TW que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 CA · MX · TW 有记录（未在本表显示）。另有 5 個規格/劑型僅在 CA · MX · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.